Tower Bridge Advisors Eli Lilly & CO Transaction History

Tower Bridge Advisors

$900 Billion
Q2 2024

A detailed history of Tower Bridge Advisors transactions in Eli Lilly & CO stock. As of the latest transaction made, Tower Bridge Advisors holds 6,039 shares of LLY stock, worth $5.45 Million. This represents 0.61% of its overall portfolio holdings.

Number of Shares

6,039

Previous 6,101 1.02%

Holding current value

$5.45 Million

Previous $4.75 Billion 15.2%

% of portfolio

0.61%

Previous 0.48%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 24, 2024	SELL	$724.87 - $909.04 $44,941 - $56,360	-62 Reduced 1.02%	6,039 $5.47 Billion
Q1 2024 Apr 29, 2024	SELL	$592.2 - $792.28 $592,792 - $793,072	-1,001 Reduced 14.09%	6,101 $4.75 Billion
Q4 2023 Feb 14, 2024	BUY	$525.19 - $619.13 $32,561 - $38,386	62 Added 0.88%	7,102 $4.14 Billion
Q3 2023 Nov 01, 2023	SELL	$434.7 - $599.3 $434 - $599	-1 Reduced 0.01%	7,040 $3.78 Billion
Q2 2023 Jul 20, 2023	BUY	$350.74 - $468.98 $367,926 - $491,960	1,049 Added 17.51%	7,041 $3.3 Billion
Q4 2022 Jan 27, 2023	SELL	$321.55 - $374.67 $4,823 - $5,620	-15 Reduced 0.25%	5,992 $2.19 Billion
Q3 2022 Nov 14, 2022	SELL	$296.48 - $337.87 $13,341 - $15,204	-45 Reduced 0.74%	6,007 $1.94 Billion
Q2 2022 Jul 21, 2022	SELL	$278.73 - $327.27 $471,053 - $553,086	-1,690 Reduced 21.83%	6,052 $1.96 Billion
Q1 2022 May 05, 2022	BUY	$234.69 - $291.66 $269,893 - $335,409	1,150 Added 17.45%	7,742 $2.22 Billion
Q4 2021 Feb 09, 2022	SELL	$224.85 - $279.04 $359,760 - $446,464	-1,600 Reduced 19.53%	6,592 $1.82 Billion
Q3 2021 Oct 28, 2021	BUY	$221.6 - $272.71 $180,825 - $222,531	816 Added 11.06%	8,192 $1.89 Billion
Q2 2021 Aug 10, 2021	BUY	$180.55 - $233.54 $399,557 - $516,824	2,213 Added 42.86%	7,376 $1.69 Billion
Q1 2021 May 12, 2021	BUY	$164.32 - $212.72 $213,616 - $276,536	1,300 Added 33.65%	5,163 $965 Million
Q4 2020 Feb 11, 2021	BUY	$130.46 - $172.63 $503,966 - $666,869	3,863 New	3,863 $652 Million

Others Institutions Holding LLY

# of Institutions

3,865

Shares Held

751M

Call Options Held

6.34M

Put Options Held

7.97M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $858B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Bridge Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Tower Bridge Advisors with notifications on news.

Account

Tower Bridge Advisors Eli Lilly & CO Transaction History